← All organizations
Highest phase reached
Phase 2
First clinical trial
May 16, 2019Last known activity
Nov 30, 2025
Timeline
2000s
- Jan 1, 2000
Oryzon Genomics S.A.— Founded
Drugs by trial phase (7 distinct, 6 trials)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Indications
Studied for
Recent trials (9)
- NCT07113691CollaboratorPhase 1Nov 30, 2025
- NCT06357182CollaboratorPhase 1Sep 16, 2024
- NCT05420636CollaboratorPhase 2Dec 31, 2022
- NCT05546580Study chairPhase 1Oct 15, 2022
- NCT05546580Lead sponsorPhase 1Oct 15, 2022
- NCT04932291Lead sponsorPhase 2Mar 26, 2021
- NCT04932291Study directorPhase 2Mar 26, 2021
- NCT03867253Lead sponsorPhase 2May 16, 2019
- NCT03867253Study directorPhase 2May 16, 2019
Details
- Founded
- Barcelona, ES Jan 1, 2000
- Last known activity
- Nov 30, 2025